A Mouse Model of Amyloid β Oligomers: Their Contribution to Synaptic Alteration, Abnormal Tau Phosphorylation, Glial Activation, and Neuronal Loss In Vivo

Alzheimer's Disease Is a Synaptic Failure

Selkoe, D. J. (2002) · Science · doi:10.1126/science.1074069 · Cited by 4,420

Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo

Walsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., & Selkoe, D. J. (2002) · Nature · doi:10.1038/416535a · Cited by 4,291

Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice

Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F., & Cole, G. (1996) · Science · doi:10.1126/science.274.5284.99 · Cited by 4,210

Triple-Transgenic Model of Alzheimer’s Disease with Plaques and Tangles

Oddo, S., Caccamo, A., Shepherd, J. D., Murphy, M. P., Golde, T. E., Kayed, R., Metherate, R., Mattson, M. P., Akbari, Y., & LaFerla, F. M. (2003) · Neuron · doi:10.1016/s0896-6273(03)00434-3 · Cited by 4,126

Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis

Kayed, R., Head, E., Thompson, J. L., McIntire, T. M., Milton, S. C., Cotman, C. W., & Glabe, C. G. (2003) · Science · doi:10.1126/science.1079469 · Cited by 4,064

Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory

Shankar, G. M., Li, S., Mehta, T. H., Garcia-Munoz, A., Shepardson, N. E., Smith, I., Brett, F. M., Farrell, M. A., Rowan, M. J., Lemere, C. A., et al. (2008) · Nature Medicine · doi:10.1038/nm1782 · Cited by 3,685

Intraneuronal β-Amyloid Aggregates, Neurodegeneration, and Neuron Loss in Transgenic Mice with Five Familial Alzheimer's Disease Mutations: Potential Factors in Amyloid Plaque Formation

Oakley, H., Cole, S. L., Logan, S., Maus, E., Shao, P., Craft, J., Guillozet-Bongaarts, A., Ohno, M., Disterhoft, J., Van Eldik, L., et al. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.1202-06.2006 · Cited by 3,530 · cited 4×

Diffusible, nonfibrillar ligands derived from Aβ 1–42 are potent central nervous system neurotoxins

Lambert, M. P., Barlow, A. K., Chromy, B. A., Edwards, C., Freed, R., Liosatos, M., Morgan, T. E., Rozovsky, I., Trommer, B., Viola, K. L., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6448 · Cited by 3,506

NeuN, a neuronal specific nuclear protein in vertebratesxs

Mullen, R. J., Buck, C. R., & Smith, A. M. (1992) · Development · doi:10.1242/dev.116.1.201 · Cited by 2,351

Albumin Exchange in Alzheimer's Disease: Might CSF Be an Alternative Route to Plasma?

Menéndez‐González, M., & Gasparovic, C. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.01036 · Cited by 28

The effect of beta-amyloid and tau protein aggregations on magnetic susceptibility of anterior hippocampal laminae in Alzheimer's diseases

Zhao, Z., Zhang, L., Wen, Q., Luo, W., Zheng, W., Liu, T., Zhang, Y., Zhu, K., & Wu, D. (2021) · NeuroImage · doi:10.1016/j.neuroimage.2021.118584 · Cited by 30

TDP-43: A new player on the AD field?

Youmans, K. L., & Wolozin, B. L. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2012.05.018 · Cited by 28

Vitamin B1-deficient mice show impairment of hippocampus-dependent memory formation and loss of hippocampal neurons and dendritic spines: potential microendophenotypes of Wernicke–Korsakoff syndrome

Inaba, H., Kishimoto, T. E., Oishi, S., Nagata, K., Hasegawa, S., Watanabe, T., & Kida, S. (2016) · Bioscience Biotechnology and Biochemistry · doi:10.1080/09168451.2016.1224639 · Cited by 28

A Toxic Conformer of Aβ42 with a Turn at 22–23 is a Novel Therapeutic Target for Alzheimer’s Disease

Izuo, N., Kasahara, C., Murakami, K., Kume, T., Maeda, M., Irie, K., Yokote, K., & Shimizu, T. (2017) · Scientific Reports · doi:10.1038/s41598-017-11671-6 · Cited by 28

Amyloid-β Aggregation Inhibitory and Neuroprotective Effects of Xanthohumol and its Derivatives for Alzheimer’s Diseases

Wang, X., Ho, S., Poon, C., Yan, T., Li, H., & Wong, M. S. (2019) · Current Alzheimer Research · doi:10.2174/1567205016666190827123222 · Cited by 26

Most dystrophic neurites in the common 5xFAD Alzheimer mouse model originate from axon terminals

Mabrouk, R., Miettinen, P. O., & Tanila, H. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106150 · Cited by 27

Gnetin C, a resveratrol dimer, reduces amyloid-β 1–42 (Aβ42) production and ameliorates Aβ42-lowered cell viability in cultured SH-SY5Y human neuroblastoma cells

SEINO, S., KIMOTO, T., Yoshida, H., Tanji, K., Matsumiya, T., Hayakari, R., Seya, K., Kawaguchi, S., Tsuruga, K., Tanaka, H., et al. (2018) · Biomedical Research · doi:10.2220/biomedres.39.105 · Cited by 27

Cerebral Amyloid Angiopathy, Alzheimer’s Disease and MicroRNA: miRNA as Diagnostic Biomarkers and Potential Therapeutic Targets

Furr, J. W., Morales‐Scheihing, D., Manwani, B., Lee, J., & McCullough, L. D. (2019) · NeuroMolecular Medicine · doi:10.1007/s12017-019-08568-0 · Cited by 29

AβPP Accumulation and/or Intraneuronal Amyloid-β Accumulation? The 3xTg-AD Mouse Model Revisited

Wirths, O., Dins, A., & Bayer, T. A. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-111529 · Cited by 26

Intraneuronal β‐amyloid and its interactions with proteins and subcellular organelles

Penke, B., Tóth, A. M., Földi, I., Szűcs, M., & Janáky, T. (2012) · Electrophoresis · doi:10.1002/elps.201200297 · Cited by 26

Prelysosomal Compartments in the Unconventional Secretion of Amyloidogenic Seeds

Madsen, H. B., & Vilhardt, F. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18010227 · Cited by 26

Mutation-induced loss of APP function causes GABAergic depletion in recessive familial Alzheimer’s disease: analysis of Osaka mutation-knockin mice

Umeda, T., Kimura, T., Yoshida, K., Takao, K., Fujita, Y., Matsuyama, S., Sakai, A., Yamashita, M., Yamashita, Y., Ohnishi, K., et al. (2017) · Acta Neuropathologica Communications · doi:10.1186/s40478-017-0461-5 · Cited by 26

Amyloid-β oligomers in the nucleus accumbens decrease motivation via insertion of calcium-permeable AMPA receptors

Guo, C., Wen, D., Zhang, Y. H., Mustaklem, R., Mustaklem, B., Zhou, M., Ma, T., & Ma, Y. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01459-0 · Cited by 24

Glycyrrhiza and Uncaria Hook contribute to protective effect of traditional Japanese medicine yokukansan against amyloid β oligomer-induced neuronal death

Kanno, H., Kawakami, Z., Iizuka, S., Tabuchi, M., Mizoguchi, K., Ikarashi, Y., & Kase, Y. (2013) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2013.06.052 · Cited by 25

Alzheimer's Toxic Amyloid Beta Oligomers: Unwelcome Visitors to the Na/K ATPase alpha3 Docking Station.

DiChiara, T., DiNunno, N., Clark, J. R., Bu, R. L., Cline, E. N., Rollins, M. G., Gong, Y., Brody, D. L., Sligar, S. G., Velasco, P. T., et al. (2017) · PubMed · Cited by 25

GTP energy dependence of endocytosis and autophagy in the aging brain and Alzheimer’s disease

Santana-Martínez, R. A., Pinky, P. D., Harlan, B. A., & Brewer, G. J. (2023) · GeroScience · doi:10.1007/s11357-022-00717-x · Cited by 26

Peripheral administration of nanomicelle-encapsulated anti-Aβ oligomer fragment antibody reduces various toxic Aβ species in the brain

Amano, A., Sanjo, N., Araki, W., Anraku, Y., Nakakido, M., Matsubara, E., Tomiyama, T., Nagata, T., Tsumoto, K., Kataoka, K., et al. (2023) · Journal of Nanobiotechnology · doi:10.1186/s12951-023-01772-y · Cited by 26

Mislocalization of CDK11/PITSLRE, a regulator of the G2/M phase of the cell cycle, in Alzheimer disease

Bajić, V., Su, B., Lee, H., Kudo, W., Siedlak, S. L., Živković, L., Spremo‐Potparević, B., Djelić, N., Milićević, Z., Singh, A., et al. (2011) · Cellular & Molecular Biology Letters · doi:10.2478/s11658-011-0011-2 · Cited by 24

Behavioral and SCN neurophysiological disruption in the Tg-SwDI mouse model of Alzheimer's disease

Paul, J. R., Munir, H. A., van Groen, T., & Gamble, K. L. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.03.007 · Cited by 23

Dysregulation of Elongation Factor 1A Expression is Correlated with Synaptic Plasticity Impairments in Alzheimer’s Disease

Beckelman, B. C., Day, S. M., Zhou, X., Donohue, M., Gouras, G. K., Klann, E., Keene, C. D., & Ma, T. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160036 · Cited by 29

Cyclooxygenase-2 is Essential for Mediating the Effects of Calcium Ions on Stimulating Phosphorylation of Tau at the Sites of Ser 396 and Ser 404

Cao, L., Guan, P.-P., Liang, Y.-Y., Huang, X., & Wang, P. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-181066 · Cited by 22

Inhibition of Amyloid β-Induced Lipid Membrane Permeation and Amyloid β Aggregation by K162

Mrđenović, D., Zarzycki, P., Majewska, M., Pieta, I. S., Nowakowski, R., Kutner, W., Lipkowski, J., & Pięta, P. (2021) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.0c00754 · Cited by 22

Transgenic Mouse Models for the Study of Neurodegenerative Diseases

Marín‐Moreno, A., Canoyra, S., Fernández‐Borges, N., Espinosa, J. C., & Torres, J. M. (2023) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2801021 · Cited by 21

Proteomic analysis of the brain tissues from a transgenic mouse model of amyloid β oligomers

Takano, M., Kouji, M., Otani, M., Sano, K., Nakamura‐Hirota, T., Tokuyama, S., Min, K. S., Tomiyama, T., Mori, H., & Matsuyama, S. (2012) · Neurochemistry International · doi:10.1016/j.neuint.2012.05.018 · Cited by 21

Oral Triphenylmethane Food Dye Analog, Brilliant Blue G, Prevents Neuronal Loss in APPSwDI/NOS2-/- Mouse Model

Irwin, J. A., Erişir, A., & Kwon, I. (2016) · Current Alzheimer Research · doi:10.2174/1567205013666160208142456 · Cited by 21

Oligomeric amyloid β preferentially targets neuronal and not glial mitochondrial‐encoded mRNAs

Mastroeni, D., Nolz, J., Khdour, O. M., Sekar, S., Delvaux, E., Cuyugan, L., Liang, W. S., Hecht, S. M., & Coleman, P. D. (2018) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2017.12.005 · Cited by 21

Nasal Rifampicin Improves Cognition in a Mouse Model of Dementia with Lewy Bodies by Reducing α-Synuclein Oligomers

Umeda, T., Hatanaka, Y., Sakai, A., & Tomiyama, T. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168453 · Cited by 22

The Immune System as a Therapeutic Target for Alzheimer’s Disease

Zieneldien, T., Kim, J., Sawmiller, D. R., & Cao, C. (2022) · Life · doi:10.3390/life12091440 · Cited by 19

Increased GADD34 in oligodendrocytes in Alzheimer’s disease

Honjo, Y., Ayaki, T., Tomiyama, T., Horibe, T., Ito, H., Mori, H., Takahashi, R., & Kawakami, K. (2015) · Neuroscience Letters · doi:10.1016/j.neulet.2015.06.052 · Cited by 19

Alzheimer Disease: The Role of Aβ in the Glutamatergic System

Campos‐Peña, V., & Antônio, M. (2014) · InTech eBooks · doi:10.5772/57367 · Cited by 24

Characterization of a Mouse Model of Alzheimer’s Disease Expressing Aβ4-42 and Human Mutant Tau

Zampar, S., & Wirths, O. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22105191 · Cited by 18

Human Induced Pluripotent Stem Cells and the Modelling of Alzheimer’s Disease: The Human Brain Outside the Dish

Tong, G., Izquierdo, P., & Raashid, R. A. (2017) · The Open Neurology Journal · doi:10.2174/1874205x01711010027 · Cited by 18

Nasal Rifampicin Halts the Progression of Tauopathy by Inhibiting Tau Oligomer Propagation in Alzheimer Brain Extract-Injected Mice

Umeda, T., Uekado, R., Shigemori, K., Eguchi, H., & Tomiyama, T. (2022) · Biomedicines · doi:10.3390/biomedicines10020297 · Cited by 18

Peripheral Aβ acts as a negative modulator of insulin secretion

Shigemori, K., Nomura, S., Umeda, T., Takeda, S., & Tomiyama, T. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2117723119 · Cited by 20

Endosomal trafficking and related genetic underpinnings as a hub in Alzheimer's disease

Limone, A., Veneruso, I., D’Argenio, V., & Sarnataro, D. (2022) · Journal of Cellular Physiology · doi:10.1002/jcp.30864 · Cited by 18

Immunocytochemical Characterization of Alzheimer Disease Hallmarks in APP/PS1 Transgenic Mice Treated with a New Anti-Amyloid-βVaccine

Carrera, I., Etcheverrı́a, I., Li, Y., Fernández‐Novoa, L., Lombardi, V., Vigo, C., Palacios, H. H., Benberin, V. V., Cacabelos, R., & Aliev, G. (2013) · BioMed Research International · doi:10.1155/2013/709145 · Cited by 19

Alzheimer’s Disease Amyloid β-Protein Mutations and Deletions That Define Neuronal Binding/Internalization as Early Stage Nonfibrillar/Fibrillar Aggregates and Late Stage Fibrils

Poduslo, J. F., Howell, K. G., Olson, N., Ramı́rez-Alvarado, M., & Kandimalla, K. K. (2012) · Biochemistry · doi:10.1021/bi300275g · Cited by 18

Alzheimer Aβ Assemblies Accumulate in Excitatory Neurons upon Proteasome Inhibition and Kill Nearby NAKα3 Neurons by Secretion

Komura, H., Kakio, S., Sasahara, T., Arai, Y., Takino, N., Sato, M., Satomura, K., Ohnishi, T., Nabeshima, Y.-I., Muramatsu, S., et al. (2019) · iScience · doi:10.1016/j.isci.2019.01.018 · Cited by 18

Nanoparticle Assisted Regulation of Nucleation Pathway of Amyloid Tetramer and Inhibition of Their Fibrillation Kinetics

Mondal, S., Chowdhury, S. R., Shah, M., Kumar, V., Kumar, S., & Iyer, P. K. (2019) · ACS Applied Bio Materials · doi:10.1021/acsabm.9b00128 · Cited by 18

Combining in vitro and in silico Approaches to Find New Candidate Drugs Targeting the Pathological Proteins Related to the Alzheimer's Disease

Li, H., Wang, X., Yu, H., Zhu, J., Jin, H., Wang, A., & Yang, Z. (2017) · Current Neuropharmacology · doi:10.2174/1570159x15666171030142108 · Cited by 21

Antibody 9D5 Recognizes Oligomeric Pyroglutamate Amyloid-β in a Fraction of Amyloid-β Deposits in Alzheimer's Disease without Cross-Reactivity with other Protein Aggregates

Venkataramani, V., Wirths, O., Budka, H., Härtig, W., Kovács, G. G., & Bayer, T. A. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-111379 · Cited by 17

Stability of Osaka Mutant and Wild-Type Fibril Models

Berhanu, W. M., Alred, E. J., & Hansmann, U. H. E. (2015) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.5b07987 · Cited by 17

Heavy Tau Burden with Subtle Amyloid β Accumulation in the Cerebral Cortex and Cerebellum in a Case of Familial Alzheimer’s Disease with APP Osaka Mutation

Shimada, H., Minatani, S., Takeuchi, J., Takeda, A., Kawabe, J., Wada, Y., Mawatari, A., Watanabe, Y., Shimada, H., Higuchi, M., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21124443 · Cited by 17

Validation and Characterization of a Novel Peptide That Binds Monomeric and Aggregated β-Amyloid and Inhibits the Formation of Neurotoxic Oligomers

Barr, R. K., Verdile, G., Wijaya, L. K., Morici, M., Taddei, K., Gupta, V. B., Pedrini, S., Jin, L., Nicolazzo, J. A., Knock, E., et al. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.679993 · Cited by 16

Endoplasmic Reticulum Stress Induces the Early Appearance of Pro-apoptotic and Anti-apoptotic Proteins in Neurons of Five Familial Alzheimer's Disease Mice

Shen, H., Pan, X., Zhang, J., Zeng, Y., Zhou, M., Yang, L., Ye, B., Dai, X., Zhu, Y., & Chen, X. (2016) · Chinese Medical Journal · doi:10.4103/0366-6999.194643 · Cited by 17

Rebamipide reduces amyloid-β 1-42 (Aβ42) production and ameliorates Aβ43-lowered cell viability in cultured SH-SY5Y human neuroblastoma cells.

Fukui, K., Yachi, K., Yoshida, H., Tanji, K., Matsumiya, T., Hayakari, R., Tsuruga, K., Tanaka, H., & Imaizumi, T. (2017) · Neurosciences research · doi:10.1016/j.neures.2017.05.005 · Cited by 16

Modified Snake α-Neurotoxin Averts β-Amyloid Binding to α7 Nicotinic Acetylcholine Receptor and Reverses Cognitive Deficits in Alzheimer’s Disease Mice

Fonar, G., Polis, B., Sams, D. S., Levi, A., Malka, A., Bal, N. V., Maltsev, A. V., Elliott, E., & Samson, A. O. (2021) · Molecular Neurobiology · doi:10.1007/s12035-020-02270-0 · Cited by 16

Rodent Models of Alzheimer’s Disease: Past Misconceptions and Future Prospects

Collins, H. M., & Greenfield, S. A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25116222 · Cited by 21

Region-specific neuron and synapse loss in the hippocampus of APPSL/PS1 knock-in mice

Brasnjevic, I., Lardenoije, R., Schmitz, C., van der Kolk, N. M., Dickstein, D. L., Takahashi, H., Hof, P. R., Steinbusch, H. W. M., & Rutten, B. P. F. (2013) · Translational Neuroscience · doi:10.2478/s13380-013-0111-8 · Cited by 16

New Hydroxyquinoline‐Based Derivatives as Potent Modulators of Amyloid‐β Aggregations

Fu, C., Hsu, L., Liao, Y., & Hu, M. (2016) · Archiv der Pharmazie · doi:10.1002/ardp.201500453 · Cited by 16

Prolonged Volatile Anesthetic Exposure Exacerbates Cognitive Impairment and Neuropathology in the 5xFAD Mouse Model of Alzheimer’s Disease

Han, F., Zhao, J., & Zhao, G. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210374 · Cited by 16

Bombycis excrementum Reduces Amyloid-β Oligomer-Induced Memory Impairments, Neurodegeneration, and Neuroinflammation in Mice

Moon, M., Choi, J. G., Kim, S. Y., & Oh, M. S. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-140270 · Cited by 16

E22Δ Mutation in Amyloid β‐Protein Promotes β‐Sheet Transformation, Radical Production, and Synaptotoxicity, But Not Neurotoxicity

Suzuki, T., Murakami, K., Izuo, N., Kume, T., Akaike, A., Nagata, T., Nishizaki, T., Tomiyama, T., Takuma, H., Mori, H., et al. (2010) · International Journal of Alzheimer s Disease · doi:10.4061/2011/431320 · Cited by 16

New insights on Alzheimer's disease diagnostic.

Fita, I. G., Enciu, A., & Stănoiu, B. (2011) · PubMed · Cited by 16

Calcium channel blockade attenuates abnormal synaptic transmission in the dentate gyrus elicited by entorhinal amyloidopathy

Pourbadie, H. G., Naderi, N., Janahmadi, M., Mehranfard, N., & Motamedi, F. (2016) · Synapse · doi:10.1002/syn.21915 · Cited by 16

Soluble Aβ42 Acts as Allosteric Activator of the Core Cholinergic Enzyme Choline Acetyltransferase

Kumar, A., Lana, E., Kumar, R., Lithner, C. U., & Darreh‐Shori, T. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00327 · Cited by 16

Association between variant amyloid deposits and motor deficits in FAD-associated presenilin-1 mutations: A systematic review

Zhang, S., Lei, C., Liu, P., Zhang, M., Tao, W., Liu, H., & Liu, M. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.07.003 · Cited by 16

Remodeling of projections from ventral hippocampus to prefrontal cortex in Alzheimer's mice

Xu, F., Ono, M., Ito, T., Uchiumi, O., Wang, F., Zhang, Y., Sun, P., Zhang, Q., Yamaki, S., Yamamoto, R., et al. (2020) · The Journal of Comparative Neurology · doi:10.1002/cne.25032 · Cited by 15

Targeting BACE1-mediated production of amyloid beta improves hippocampal synaptic function in an experimental model of ischemic stroke

Basak, J. M., Falk, M., Mitchell, D. N., Coakley, K. A., Quillinan, N., Orfila, J. E., & Herson, P. S. (2023) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x231159597 · Cited by 15

I716F AβPP Mutation Associates with the Deposition of Oligomeric Pyroglutamate Amyloid-β and α-Synucleinopathy with Lewy Bodies

Berger–Sieczkowski, E., Milenković, I., Venkataramani, V., Giera, R., Ströbel, T., Höftberger, R., Liberski, P. P., Auff, E., Wirths, O., Bayer, T. A., et al. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-141524 · Cited by 16

A mathematical model for Alzheimer’s disease: An approach via stochastic homogenization of the Smoluchowski equation

Franchi, B., Heida, M., & Lorenzani, S. (2020) · Communications in Mathematical Sciences · doi:10.4310/cms.2020.v18.n4.a10 · Cited by 15

Flow cytometry method to quantify the formation of beta-amyloid membrane ion channels.

Zaretsky, D. V., & Zaretskaia, M. V. (2020) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2020.183506 · Cited by 15

A potential defense mechanism against amyloid deposition in cerebellum

Shahnur, A., Nakano, M., Ishihara, S., Kakuda, N., Miyasaka, T., Uchiyama, H., Shirai, Y., Moniruzzaman, M., Saito, T., Saido, T. C., et al. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.12.036 · Cited by 15

Novel Phosphorylation-State Specific Antibodies Reveal Differential Deposition of Ser26 Phosphorylated Aβ Species in a Mouse Model of Alzheimer’s Disease

Kumar, S., Kapadia, A., Theil, S., Joshi, P., Riffel, F., Heneka, M. T., & Walter, J. (2021) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.619639 · Cited by 16

Supratherapeutic concentrations of cilostazol inhibits β-amyloid oligomerization in vitro

Shozawa, H., Oguchi, T., Tsuji, M., Yano, S., Kiuchi, Y., & Ono, K. (2018) · Neuroscience Letters · doi:10.1016/j.neulet.2018.04.032 · Cited by 15

Hyperfunction of post-synaptic density protein 95 promotes seizure response in early-stage aβ pathology

Yook, Y., Lee, K. Y., Kim, E. Y., Lizarazo, S., Yu, X., & Tsai, N. (2024) · EMBO Reports · doi:10.1038/s44319-024-00090-0 · Cited by 15

Critical thinking of Alzheimer’s transgenic mouse model: current research and future perspective

Li, X., Quan, M., Wei, Y., Wang, W., Xu, L., Wang, Q., & Jia, J. (2023) · Science China Life Sciences · doi:10.1007/s11427-022-2357-x · Cited by 14

Activation of peroxisome proliferator‐activated receptor delta suppresses BACE 1 expression by up‐regulating SOCS 1 in a JAK 2/ STAT 1‐dependent manner

Lee, W. J., Ham, S. A., Lee, G. H., Choi, M., Yoo, H., Paek, K. S., Lim, D., Hong, K., Hwang, J. S., & Seo, H. G. (2019) · Journal of Neurochemistry · doi:10.1111/jnc.14715 · Cited by 13

The type of Aβ-related neuronal degeneration differs between amyloid precursor protein (APP23) and amyloid β-peptide (APP48) transgenic mice

Upadhaya, A. R., Scheibe, F., Kosterin, I., Abramowski, D., Gerth, J., Kumar, S., Liebau, S., Yamaguchi, H., Walter, J., Staufenbiel, M., et al. (2013) · Acta Neuropathologica Communications · doi:10.1186/2051-5960-1-77 · Cited by 14

Effect of amyloids on the vesicular machinery: implications for somatic neurotransmission

Das, A. K., Pandit, R., & Maiti, S. (2015) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2014.0187 · Cited by 14

The E693Δ (Osaka) mutation in amyloid precursor protein potentiates cholesterol‐mediated intracellular amyloid β toxicity via its impaired cholesterol efflux

Nomura, S., Umeda, T., Tomiyama, T., & Mori, H. (2013) · Journal of Neuroscience Research · doi:10.1002/jnr.23278 · Cited by 13

Amyloid β and Amyloid Precursor Protein Synergistically Suppress Large-Conductance Calcium-Activated Potassium Channel in Cortical Neurons

Yamamoto, K., Yamamoto, R., & Kato, N. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.660319 · Cited by 13

Unique molecular signatures of Alzheimer's disease amyloid β peptide mutations and deletion during aggregate/oligomer/fibril formation

Poduslo, J. F., & Howell, K. G. (2014) · Journal of Neuroscience Research · doi:10.1002/jnr.23507 · Cited by 15

An Essential Role for Alzheimer’s-Linked Amyloid Beta Oligomers in Neurodevelopment: Transient Expression of Multiple Proteoforms during Retina Histogenesis

Bartley, S. C., Proctor, M. T., Xia, H., Ho, E., Kang, D. S., Schuster, K. H., Bicca, M. A., Seckler, H. S., Viola, K. L., Patrie, S. M., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23042208 · Cited by 14

2) Amyloid β Protein

Tamaoka, A. (2011) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.100.2469 · Cited by 14

Cellular prion protein and Alzheimer disease

Kudo, W., Petersen, R. B., & Lee, H. (2013) · Prion · doi:10.4161/pri.22848 · Cited by 12

Decreased levels of PDI and P5 in oligodendrocytes in Alzheimer's disease

Honjo, Y., Ayaki, T., Tomiyama, T., Horibe, T., Ito, H., Mori, H., Takahashi, R., & Kawakami, K. (2017) · Neuropathology · doi:10.1111/neup.12395 · Cited by 12

Somatostatin: Linking Cognition and Alzheimer Disease to Therapeutic Targeting

Sandoval, K. E., & WITT, K. A. (2024) · Pharmacological Reviews · doi:10.1124/pharmrev.124.001117 · Cited by 14

Lipid role in synapse and nuclear envelope-associated endocytic pathways in Tauopathy

Chinnathambi, S., Adithyan, A., & Chandrashekar, M. (2024) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2024.08.002 · Cited by 11

Peptide-loaded chitosan nanoparticles improve mitochondrial and cognitive functions via inhibition of Aβ-ABAD interaction in Alzheimer’s disease

Youssef, Y. A., Tammam, S. N., El-Shenawy, B. M., Ilyas, S., Gad, A. A., Farag, K. S., Mathur, S., & Abdel-Kader, R. M. (2025) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2025.114778 · Cited by 12

Proteomic analysis involved with synaptic plasticity improvement by GABAA receptor blockade in hippocampus of a mouse model of Alzheimer’s disease

Kadoyama, K., Matsuura, K., Takano, M., Otani, M., Tomiyama, T., Mori, H., & Matsuyama, S. (2020) · Neuroscience Research · doi:10.1016/j.neures.2020.04.004 · Cited by 12

The Role of RIN3 Gene in Alzheimer’s Disease Pathogenesis: a Comprehensive Review

Meshref, M. M., Ghaith, H. S., Hammad, M. A., Shalaby, M. M. M., Ayasra, F., Monib, F. A., Attia, M. S., Ebada, M. A., Elsayed, H., Shalash, A., et al. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03802-0 · Cited by 12

Toxic Amyloid-β42 Conformer May Accelerate the Onset of Alzheimer’s Disease in the Preclinical Stage

Futamura, A., Hieda, S., Mori, Y., Kasuga, K., Sugimoto, A., Kasai, H., Kuroda, T., Yano, S., Tsuji, M., Ikeuchi, T., et al. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-201407 · Cited by 10

An Update on Autophagy as a Target in the Treatment of Alzheimer’s Disease

Sose, P. M., Doshi, G., & Kale, P. P. (2023) · Current Drug Targets · doi:10.2174/1389450124666230417104325 · Cited by 10

Pathology Associated with AAV Mediated Expression of Beta Amyloid or C100 in Adult Mouse Hippocampus and Cerebellum

Drummond, E., Muhling, J., Martins, R. N., Wijaya, L. K., Ehlert, E., & Harvey, A. R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059166 · Cited by 11

A call for new approaches to Alzheimer's disease research

Coleman, P. D., & Mastroeni, D. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.04.027 · Cited by 10

The past and present of therapeutic strategy for Alzheimer’s diseases: potential for stem cell therapy

Murayama, M. A. (2023) · EXPERIMENTAL ANIMALS · doi:10.1538/expanim.22-0164 · Cited by 9

Template-Mediated Detoxification of Low-Molecular-Weight Amyloid Oligomers and Regulation of Their Nucleation Pathway

Mondal, S., Kumar, V., Chowdhury, S. R., Shah, M., Gaur, A., Kumar, S., & Iyer, P. K. (2019) · ACS Applied Bio Materials · doi:10.1021/acsabm.9b00514 · Cited by 9

Overexpression of protein kinase Mζ in the hippocampal dentate gyrus rescues amyloid-β-induced synaptic dysfunction within entorhinal-hippocampal circuit

Aliakbari, S., Sayyah, M., Mirzapourdelavar, H., Amini, N., Naghdi, N., & Pourbadie, H. G. (2021) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2021.01.017 · Cited by 9

Self-assembly pathways of E22Δ-type amyloid β peptide mutants generated from non-aggregative O-acyl isopeptide precursors

Sohma, Y., Wang, H., Taniguchi, A., Hirayama, Y., Kakizawa, T., Yamasaki, M., Mukai, H., & Kiso, Y. (2011) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2011.04.056 · Cited by 9

Transmissible long-term neuroprotective and pro-cognitive effects of 1–42 beta-amyloid with A2T icelandic mutation in an Alzheimer’s disease mouse model

Célestine, M., Jacquier‐Sarlin, M. R., Borel, E., Petit, F., Lanté, F., Bousset, L., Hérard, A., Buisson, A., & Dhénain, M. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02611-8 · Cited by 7

Are Women with Polycystic Ovary Syndrome at Increased Risk of Alzheimer Disease? Lessons from Insulin Resistance, Tryptophan and Gonadotropin Disturbances and Their Link with Amyloid-Beta Aggregation

Sobczuk, J., Paczkowska, K., Andrusiów, S., Bolanowski, M., & Daroszewski, J. (2024) · Biomolecules · doi:10.3390/biom14080918 · Cited by 8

Multi-targeted approach via apigenin-7-O-glucoside for therapeutic intervention of Tau phosphorylating kinases in Alzheimer’s disease

Prabha, S., Choudhury, A., Jawaid, T., Saeed, M. U., Thakur, S. C., & Hassan, M. I. (2025) · 3 Biotech · doi:10.1007/s13205-025-04413-3 · Cited by 8

Toward the Identification of Neurophysiological Biomarkers for Alzheimer’s Disease in Down Syndrome: A Potential Role for Cross-Frequency Phase-Amplitude Coupling Analysis

Victorino, D. B., Faber, J., Pinheiro, D. J. L. L., Scorza, F. A., de Almeida, A.-C. G., Costa, A. C. S., & Scorza, C. A. (2022) · Aging and Disease · doi:10.14336/ad.2022.0906 · Cited by 8

The Role of Aβ and Tau Oligomers in the Pathogenesis of Alzheimer’s Disease

Bhaskar, K., & Lamb, B. T. (2011) · Springer eBooks · doi:10.1007/978-94-007-2774-8_5 · Cited by 8

Deletion of SERF2 in mice delays embryonic development and alters amyloid deposit structure in the brain

Stroo, E., Janssen, L., Sin, O., Hogewerf, W., Koster, M. H., Harkema, L., Youssef, S. A., Beschörner, N., Wolters, A. H. G., Bakker, B., et al. (2023) · Life Science Alliance · doi:10.26508/lsa.202201730 · Cited by 9

Evidence from ITIR-FCS Diffusion Studies that the Amyloid-Beta (Aβ) Peptide Does Not Perturb Plasma Membrane Fluidity in Neuronal Cells

Ng, J. T. Y., Kamm, R. D., Wohland, T., & Kraut, R. S. (2018) · Journal of Molecular Biology · doi:10.1016/j.jmb.2018.04.030 · Cited by 8

The interaction between neurotransmitter receptor activity and amyloid-β pathology in Alzheimer's disease

Nong, Y., Kim, J. S., Jia, L., Arancio, O., & Wang, Q. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251342273 · Cited by 8

Liquid–liquid phase separation in neurodegenerative diseases

Haider, R., Boyko, S., & Surewicz, W. K. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-823967-4.00018-x · Cited by 7

O4‐05‐01: Intraneuronal accumulation of Aβ oligomers causes abnormal tau phosphorylation, glial activation and neuronal loss in transgenic mice with APP E693Δ mutation

Tomiyama, T., Umeda, T., Sakama, N., Lambert, M. P., Klein, W. L., & Mori, H. (2010) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2010.05.488

O2‐06‐07: A transgenic mouse model of amyloid β oligomers: Pathological effects of the E693Δ mutation in amyloid precursor protein in vivo

Tomiyama, T., Matsuyama, S., Iso, H., Takuma, H., Umeda, T., Ohnishi, K., Teraoka, R., Ishibashi, K., Nishitsuji, K., Ito, K., et al. (2009) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2009.05.367

New Alzheimer’s disease model mouse specialized for analyzing the function and toxicity of intraneuronal Amyloid β oligomers

Ochiishi, T., Kaku, M., Kiyosue, K., Doi, M., Urabe, T., Hattori, N., Shimura, H., & Ebihara, T. (2019) · Scientific Reports · doi:10.1038/s41598-019-53415-8 · Cited by 34

P4‐278: The Abeta Oligomer Selective Antibody Nab61 Recognizes Abeta Oligomers In The AD And APP Transgenic Mouse Brains And Neutralizes Abeta Mediated Synaptic Dysfunction

Lundkvist, J., Kim, L. M., Gustafsson, E., Hagström, E., Zetterberg, H., Hanse, E., von Euler, G., Leonov, S., Näslund, J., Dahlqvist, C., et al. (2009) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2009.07.059

P1–120: Small arctic Aβ aggregates disturb synaptic plasticity and behavior in transgenic mice

Knobloch, M., Farinelli, M., Konietzko, U., Mansuy, I. M., & Nitsch, R. M. (2006) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2006.05.496